AX251 LAI

AX251 LAI · Anxo Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AX251 LAI, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia [Phase 1]